Circle Internet Group (CRCL): Billionaire David Abrams Sells Position
Circle Internet Group (NYSE:CRCL) does not feature in the 13F portfolio of Abrams Capital Management for the fourth quarter of 2025.
Insider Monkey Blog
Nuvation Bio Inc. (NUVB): Billionaire David Abrams Has a Long-Term Bet on This Stock
Nuvation Bio Inc. (NYSE:NUVB) has been featured in the 13F portfolio of Abrams Capital Management since the first quarter of 2021. The stake comprises 3.81 million shares.
Energy Transfer LP (ET): Billionaire David Abrams Trims Stake
Energy Transfer LP (NYSE:ET) is among the long-term stock picks of Abrams Capital Management.
U-Haul Holding Company (UHAL): Billionaire David Abrams Continues To Be Bullish
U-Haul Holding Company (NYSE:UHAL) has been a constant feature in the 13F portfolio of Abrams Capital Management since late 2022.
Willis Towers Watson Public Limited Company (WTW): Billionaire David Abrams Likes This Stock
Willis Towers Watson Public Limited Company (NASDAQ:WTW) is among the favorite stocks of Abrams Capital Management.
Coupang, Inc. (CPNG): Billionaire David Abrams Is Betting Big on This Stock
Coupang, Inc. (NYSE:CPNG) has been a constant feature in the 13F portfolio of Abrams Capital Management for many years.
Asbury Automotive Group Inc. (ABG): Billionaire David Abrams Continues to Hold Massive Position
Asbury Automotive Group, Inc. (NYSE:ABG) is a long-term holding of Abrams Capital Management.
Somnigroup International Inc. (SGI): Billionaire David Abrams Makes Minor Adjustment to Position
Somnigroup International Inc. (NYSE:SGI) stock shares a similar story to many others in the Abrams Capital Management portfolio.
Loar Holdings Inc. (LOAR): Billionaire David Abrams Is a Big Admirer of This Stock
Loar Holdings Inc. (NYSE:LOAR) is a relatively recent addition to the 13F portfolio of Abrams Capital Management, compared to other long-term holdings.
Clarivate Plc (CLVT) in a Phase of Robust Growth Amid AI Integration
Clarivate Plc (NYSE:CLVT) is one of the cheap rising stocks to buy now.
First Advantage Corporation (FA) Targets $2B by 2028
First Advantage Corporation (NASDAQ:FA) is one of the cheap rising stocks to buy now.
H.C. Wainwright Bullish on AtaiBeckley (ATAI)
[caption id="attachment_1238589" align="aligncenter" width="1456"] A closeup of a laboratory assistant, holding up a vial of a newly developed pharmaceutical product.[/caption...
Is BBB Foods (TBBB) One of the Best Mid-Cap Consumer Defensive Stocks to Look at
As of the March 23 closing, consensus sentiment for BBB Foods Inc. (NYSE:TBBB) remained moderately bullish.
BellRing Brands (BRBR) Well-Positioned for “Easy Protein” Boom
On March 16, Kaumil Gajrawala from Jefferies reduced the firm’s price target on BellRing Brands Inc. (NYSE:BRBR) from $38 to $28.
What Does the Recent Volumetric Slowdown Mean for Elf Beauty (ELF)
On March 9, Piper Sandler highlighted that the February consumption data for e.l.f. Beauty Inc. (NYSE:ELF) declined to a flat level, a 5-point deceleration from January.
What Makes Primo Brands (PRMB) So Attractive
On February 27, Nik Modi from RBC Capital increased the firm’s price target on Primo Brands Corporation (NYSE:PRMB) from $26 to $29.
Freshpet (FRPT) Upgraded to Outperform by Oppenheimer
On March 20, Oppenheimer upgraded Freshpet Inc. (NASDAQ:FRPT) from Perform to Outperform. The firm set a target price of $80 for the stock, implying an almost 24% upside.
Ollie’s Bargain Outlet (OLLI) Positioned to Capitalize on One Big Beautiful Bill Tailwind
On March 13, Ollie’s Bargain Outlet Holdings Inc. (NASDAQ:OLLI) was subject to a rating upgrade by Wells Fargo, from Equal Weight to Overweight.
What Does This $450 Million Acquisition Mean for Smithfield Foods (SFD)
On March 9, Smithfield Foods Inc. (NASDAQ:SFD) shared that the company is expected to complete its $450 million acquisition of Nathan’s Famous Inc.
VisionSys AI (VSA) Soars 140% After Exchange Non-Compliance
VisionSys soared by 140.35 percent on Thursday to close at $1.37 apiece, as investors gobbled up shares to support its price boost after falling below the exchange requirement...
Kodiak Sciences (KOD) Climbs 75% on Stellar Clinical Results
Kodiak Sciences soared by 74.77 percent on Thursday to finish at $39.76 apiece, as investors took heart from the strong results of its clinical study for its diabetic retinopathy...
Analyst Sentiment Remains Strong on Adobe (ADBE) Amid Ongoing Regulatory Challenges
As of March 20, 2026, Adobe Inc. (NASDAQ:ADBE) boasts a consensus price target of $310.00, implying a potential upside of 24.21%.
Needham Bullish on Zoom Communications (ZM) Amid Growing AI Momentum
As of March 20, 2026, analysts remain constructive toward Zoom Communications, Inc. (NASDAQ:ZM), with 56% of analysts covering the stock maintaining bullish ratings.
RBC Cautious on DocuSign (DOCU) Following Fourth-Quarter Results
As of March 18, 2026, analysts have taken a cautious approach toward DocuSign, Inc.
Analysts Remain Mixed on BlackLine (BL) Amid Company’s Agentic AI Plans
As of March 20, 2026, roughly 44% of analysts covering BlackLine, Inc. (NASDAQ:BL) remain bullish, while 50% of them remain cautious.
Analysts Bullish on Salesforce (CRM) Amid New AI Launches and Insider Purchases
As of March 20, 2026, 75% of analysts covering the stock retain “Buy” ratings for Salesforce, Inc.
Analysts Remain Confident in Workday (WDAY)’s Outlook Amid Strong AI Momentum
As of March 20, 2026, 60% of analysts covering the stock retain bullish ratings for Workday, Inc.
Analysts Remain Constructive on Freshworks (FRSH) Amid Broader Headwinds
As of March 20, 2026, Freshworks Inc.
Analyst Sentiment Remains Strong on Atlassian (TEAM) Amid Its Transition Toward AI and Enterprise Sales
As of March 20, 2026, analyst sentiment toward the company remains bullish.
Navan (NAVN) Skyrockets 43% as 3 Analysts ‘Bullish’
Navan soared by 43.28 percent on Thursday to finish at $13.11 apiece, as investors took heart from its strong revenue performance as well as three analysts’ bullish ratings ...
NextDecade (NEXT) Soars 11% on US-Iran Uncertainties
NextDecade rallied for a third straight day on Thursday, jumping 11.04 percent to finish at $8.15 apiece, as investors poured funds back into oil and gas stocks over growing doubts...
Brown-Forman (BF-B) Climbs 9.6% on Pernod Ricard Merger
Brown-Forman grew its share prices by 9.58 percent on Thursday to finish at $25.74 apiece, as investors loaded portfolios following news that it is set to merge with Pernod Ricard...
Braze (BRZE) Climbs 7.9% on Bullish Rating
Braze rallied for a second day on Thursday, jumping 7.92 percent to close at $23.31 apiece, as investors took heart from an investment firm’s bullish rating and price target...
JBS NV (JBS) Climbs to 7-Month High on Robust Earnings
Based on its financial statement, JBS NV (NYSE:JBS) grew its attributable net income by 14.5 percent to $2.02 billion from $1.767 billion in 2024.
Figma Inc. (FIG) Rallies 5% on Bargain-Hunting
The stock is noticeably trading at the lower end of its 52-week price range, having dipped to $20.93 in intra-day trading on Thursday, or just $1.08 shy of its 52-week low of $...
Best Buy (BBY) Climbs 4.6% on Higher Dividends
Best Buy saw its share prices jump by 4.65 percent on Thursday to close at $63.21 apiece, as investor sentiment was boosted by the consistent increase in its annual dividends, ...
Occidental Petroleum (OXY) Soars to 52-Week High on Leadership Transition
In intra-day trading, Occidental Petroleum Corp.
10 Stocks Dominating The Market Today: Best Buy, Figma, Navan, and More
Ten stocks stood firmer on Thursday, bucking a bloodbath in the broader market, as investors took heart from corporate developments such as strong earnings and outlooks, among...
5 Stocks Dominating The Market Today
Brown-Forman grew its share prices by 9.58 percent on Thursday to finish at $25.74 apiece, as investors loaded portfolios following news that it is set to merge with Pernod Ricard...
Guggenheim Sees Favorable Risk-Reward for Pfizer (PFE) Ahead of Phase 3 Data
On March 24, Guggenheim Partners raised its price recommendation on Pfizer Inc. (NYSE:PFE) to $36 from $35. It reiterated a Buy rating on the shares.
Truist Cuts CubeSmart (CUBE) Target, Updates REIT Outlook after Q4
On March 26, Truist Financial trimmed its price recommendation on CubeSmart (NYSE:CUBE) to $41 from $42. It kept a Buy rating on the shares.
Wells Fargo Upgrades Enterprise Products (EPD) to Overweight on Permian Growth Outlook
On March 25, Wells Fargo upgraded Enterprise Products Partners L.P. (NYSE:EPD) to Overweight from Equal Weight. It raised the stock’s price target to $42 from $40.
Goldman Sachs, Citi Raise Verizon (VZ) Targets, Highlight Shift to EBITDA and Cash Flow Focus
On March 25, Goldman Sachs analyst Michael Ng raised the price recommendation on Verizon Communications Inc. (NYSE:VZ) to $55 from $50.
Truist Keeps Buy on U.S. Bancorp (USB) Despite Pressure from Rates and Macro Risks
On March 26, Truist Financial lowered its price recommendation on U.S. Bancorp (NYSE:USB) to $63 from $66.
Scotiabank Sees Iran Conflict as Neutral for Kinder Morgan (KMI), Lifts PT
On March 26, Scotiabank raised its price recommendation on Kinder Morgan, Inc. (NYSE:KMI) to $32 from $31.
Rothschild Cuts Mondelez (MDLZ) to Neutral, Cites Volume Weakness and Rising Competition
On March 25, Rothschild & Co Redburn downgraded Mondelez International, Inc. (NASDAQ:MDLZ) to Neutral from Buy. It lowered the stock’s price target to $55 from $71.
Morgan Stanley Boosts AEP PT, Highlights Constructive Utility Sector Outlook
On March 23, Morgan Stanley raised its price recommendation on American Electric Power Company, Inc. (NASDAQ:AEP) to $137 from $133.
RBC Reiterates Merck (MRK) Outperform, Notes Investor Concerns Over “Modest Premium”
On March 25, RBC reiterated an Outperform rating on Merck & Co., Inc. (NYSE:MRK) with a $142 price target.
Bernstein Lowers Qualcomm (QCOM) PT, Says Expectations “Now Appear Much Too High”
On March 26, Bernstein Research downgraded QUALCOMM Incorporated (NASDAQ:QCOM) to Market Perform from Outperform. It cut its price target to $140 from $175.
Gilead to Acquire Ouro Medicines in $2.18B Deal, Expand Inflammation Pipeline
On March 23, The Wall Street Journal reported that Gilead Sciences, Inc.
Hedge Fund Resource Center
